Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced - A randomized intervention study

被引:27
作者
Fagerberg, B [1 ]
Wikstrand, J
Berglund, G
Samuelsson, O
Agewall, S
机构
[1] Gothenburg Univ, Sahlgrens Hosp, Dept Med, S-41345 Gothenburg, Sweden
[2] Gothenburg Univ, Sahlgrens Hosp, Dept Nephrol, S-41345 Gothenburg, Sweden
[3] Gothenburg Univ, Sahlgrens Hosp, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden
[4] Lund Univ, Malmo Hosp, Dept Med, Malmo, Sweden
[5] Astra Hassle AB, Cardiovasc Res Lab, Molndal, Sweden
关键词
hypertension; hypercholesterolemia; diabetes mellitus; smoking; mortality;
D O I
10.1016/S0895-7061(97)00363-4
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim was to examine the feasibility and efficacy of a multifactorial risk factor intervention program in hypertensive patients at high cardiovascular risk, Treated hypertensive men, aged 50 to 72 years, with at least one of the following: serum cholesterol concentration greater than or equal to 6.5 mmol/L, diabetes mellitus, or smoking were randomized to multifactorial risk factor intervention (n = 253) or usual care (n = 255). The specific intervention was based on group meetings to encourage a lipid lowering diet and smoking cessation. Cholestyramine, nicotinic acid, fibrates, and later statins were used either as single drug therapy or in combination, following agreed guidelines in patients in whom the nonpharmacological intervention was judged to be insufficient. Usual care was given according to clinical practice. The median follow-up lime was 6.6 years. Sixty-four patients (25.1%) died in the usual care group, compared with 41 patients (16.2%) in the intervention group (P = .016; 95% confidence interval, relative risk 0.42 to 0.92). The overall risk for fatal and nonfatal cardiovascular events was 29% lower in the intervention group than in the usual care group (P = .041). Relative to usual care, fire intervention program lowered mean in-trial serum concentrations of total cholesterol (6.3%, P < .0001), LDL cholesterol (9.1%, P < .0001), and blood glucose (0.2 mmol/L, P < .05). Among smokers, at entry, cotinine-adjusted quit rates were 28% in the intervention group and 11% in the usual care group (P = .012) after 3 years. This study illustrates the very high cardiovascular risk in hypertensive patients 50 to 72 years of age with additional risk factors. The results indicate, however, that the gloomy prognosis may be improved by a dedicated risk factor intervention program. (C) 1998 American Journal of Hypertension, Ltd.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 31 条
[1]   THE EFFICACY OF MULTIPLE RISK FACTOR INTERVENTION IN TREATED HYPERTENSIVE MEN DURING LONG-TERM FOLLOW-UP [J].
AGEWALL, S ;
WIKSTRAND, J ;
SAMUELSSON, O ;
PERSSON, B ;
ANDERSSON, OK ;
FAGERBERG, B .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :651-659
[2]  
Agewall S, 1995, J HYPERTENS, V13, P1471
[3]  
AGEWALL S, 1993, NUTR METAB CARDIOVAS, V3, P128
[4]  
ANDERSSON O, 1978, ACTA MED SCAND, V203, P391
[5]  
CLEEMAN JI, 1988, ARCH INTERN MED, V148, P36, DOI 10.1001/archinte.148.1.36
[6]  
*DRUG INF COMM, 1989, TREATM HYP
[7]   Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans [J].
Fagerberg, B ;
Wiklund, O ;
Agewall, S ;
Camejo, G ;
Wikstrand, RJ .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1996, 26 (11) :960-965
[8]   CHOLESTEROL REDUCTION YIELDS CLINICAL BENEFIT - A NEW LOOK AT OLD DATA [J].
GOULD, AL ;
ROSSOUW, JE ;
SANTANELLO, NC ;
HEYSE, JF ;
FURBERG, CD .
CIRCULATION, 1995, 91 (08) :2274-2282
[9]  
HJERMANN I, 1981, LANCET, V2, P1303
[10]   COMPARISON OF TESTS USED TO DISTINGUISH SMOKERS FROM NONSMOKERS [J].
JARVIS, MJ ;
TUNSTALLPEDOE, H ;
FEYERABEND, C ;
VESEY, C ;
SALOOJEE, Y .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1987, 77 (11) :1435-1438